 |
|
polyvalent melanoma vaccine
A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | Polyvalent Melanoma Cell Vaccine | | | | US brand name: | | Canvaxin | | | | Abbreviations: | | PMCV
POLYMELVAC | | |
|
|
